Top compounds associated with response to CLCN4


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.08
mRNA BRD-K09344309 CTRPv2 pan-cancer AAC 0.13 0.08
mRNA AR-42 GDSC1000 pan-cancer AAC 0.052 0.08
mRNA linifanib CTRPv2 pan-cancer AAC -0.061 0.08
mRNA T0901317 GDSC1000 pan-cancer AAC 0.057 0.08
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.09
mRNA barasertib CTRPv2 pan-cancer AAC -0.054 0.09
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.058 0.09
mRNA PLX4720 CCLE pan-cancer AAC -0.074 0.09
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.051 0.09
Download CSV